MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GlaxoSmithKline plc Company Profile (NYSE:GSK)

Consensus Ratings for GlaxoSmithKline plc (NYSE:GSK) (?)
Ratings Breakdown: 1 Sell Rating(s), 9 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $47.25 (15.81% upside)

Analysts' Ratings History for GlaxoSmithKline plc (NYSE:GSK)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Bank of AmericaReiterated RatingBuy$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Oddo SecuritiesUpgradeReduce -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cantor FitzgeraldInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Sanford C. BernsteinBoost Price TargetMarket Perform$43.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bryan, Garnier & CoUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/21/2015Leerink SwannReiterated RatingMarket Perform$48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015ArgusLower Price TargetBuy$52.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Morgan StanleyReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2015Societe GeneraleReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2015Credit SuisseUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015BNP ParibasUpgradeUnderperform -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015Liberum CapitalUpgradeSell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Berenberg BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015BarclaysReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Kepler Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015S&P Equity ResearchDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015New Street ResearchDowngradeReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Jefferies GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2014Main First Bank AGDowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for GlaxoSmithKline plc (NYSE:GSK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
2/3/2016Q415$0.18$0.18$6.28 billion$6.29 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q3$0.60$0.71$6.07 billion$6.13 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.50$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.55$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q414$0.86$0.82$6.14 billion$6.19 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.79$0.90ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q114$0.71$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q413$0.72$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014Q4$0.30$0.30$6.84 billion$6.91 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$0.31$10.31 billion$10.09 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013$0.26$0.26$6.62 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.29$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2012$0.30$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for GlaxoSmithKline plc (NYSE:GSK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.50$0.50$0.50
Q2 20161$0.60$0.60$0.60
Q3 20161$0.74$0.74$0.74
Q4 20161$0.70$0.70$0.70
(Data provided by Zacks Investment Research)
Current Dividend Information for GlaxoSmithKline plc (NYSE:GSK)
Annual Dividend:$2.20
Dividend Yield:5.39%
Payout Ratio:85.27%
Dividend Growth:2.50% (3 Year Average)

Dividend History for GlaxoSmithKline plc (NYSE:GSK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/28/2016$0.555/11/20165/13/20167/14/2016Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015$0.5811/10/201511/13/20151/14/2016Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015quarterly$0.585.22%5/13/20155/15/20157/9/2015Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015quarterly$0.706.05%2/18/20152/20/20154/9/2015Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014quarterly$0.615.41%11/5/201411/7/20141/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014quarterly$0.655.18%8/6/20148/8/201410/2/2014Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014quarterly$0.644.62%5/14/20145/16/20147/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014$0.752/19/20142/21/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014quarterly$0.755.73%2/19/20142/21/20144/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013quarterly$0.624.76%11/13/201311/15/20131/9/2014Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013quarterly$0.554.27%8/7/20138/9/201310/3/2013Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013quarterly$0.554.25%5/8/20135/10/20137/11/2013Tweet This Announcement  Share This Announcement on StockTwits
2/7/2013quarterly$0.070.61%2/20/20132/22/20134/11/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for GlaxoSmithKline plc (NYSE:GSK)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for GlaxoSmithKline plc (NYSE:GSK)
DateHeadline
06/26/16 03:49 PMGlaxosmithkline Plc (NYSE:GSK) Shorted Shares Increased 2.96% After Market Selling - Engelwood Daily
06/25/16 04:04 PMCan GlaxoSmithKline plc (ADR) Subsist Advair's Patent Expiry - Business Finance News
06/24/16 04:24 PMStocks to Keep Your Eyes on: GlaxoSmithKline plc (NYSE:GSK), Timmins Gold Corp (NYSE:TGD) - NYSE Journal (press release)
06/24/16 04:24 PMHC Stocks in Hub: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sarepta Therapeutics Inc (NASDAQ:SRPT) - share market updates (press release)
06/23/16 09:31 PMEarnings Estimates Update: GlaxoSmithKline plc (NYSE:GSK) - News Oracle
06/23/16 09:31 PMHC Stocks Newsbeat: GlaxoSmithKline plc (ADR) (NYSE:GSK), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - share market updates (press release)
06/23/16 09:31 PMNew Broker Ratings For GlaxoSmithKline PLC (NYSE:GSK) - FTSE News
06/23/16 04:20 AMWhy GlaxoSmithKline plc looks set to be beaten by Inmarsat Plc -
06/22/16 04:25 PMNSE ASI adds 2.40% as GSK, Transcorp, Neimeth add weight
06/22/16 04:25 PMGlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100's best medical marvel?
06/22/16 08:57 AMRecently Issued Stock Ratings For GlaxoSmithKline PLC (NYSE:GSK) - Fiscal Standard
06/22/16 08:57 AMStock's Ratings to Focus: GlaxoSmithKline PLC (NYSE:GSK) , Eli Lilly and Company (NYSE:LLY) - Street Updates
06/22/16 08:57 AMSummary of Analysts Rating: Celgene Corporation (NASDAQ:CELG) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/21/16 04:03 PMNSE ASI adds 2.27% as Glaxosmithkline, Champion Breweries, Access Bank lead gainers
06/21/16 08:56 AMHC Stocks Review: GlaxoSmithKline plc (ADR) (NYSE:GSK), Opko Health Inc. (NYSE:OPK) - share market updates (press release)
06/21/16 08:56 AMGlaxoSmithKline PLC (LON:GSK) price target held steady to GBX0, reported today by Beaufort Securities - Breaking Finance News
06/20/16 04:09 PMWhy GlaxoSmithKline plc (ADR) (GSK) Stock Is Higher Today - Investorplace.com
06/20/16 12:33 PMWhy GlaxoSmithKline plc (ADR) (GSK) Stock Is Higher Today - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips GlaxoSmithKline stock was up on Monday following positive results from a clinical study for a new drug designed to treat COPD. The post Why GlaxoSmithKline plc (ADR) (GSK) Stock Is Higher Today appeared first on InvestorPlace.
06/20/16 10:42 AMHow do I use previous support and resistance levels? -
06/20/16 10:33 AMGSK positive results
06/20/16 10:33 AMGlaxoSmithKline PLC (LON:GSK) price target maintained to GBX0 as recorded today by Shore Capital
06/20/16 10:33 AMGlaxoSmithKline says lung drug meets late-stage study goals
06/20/16 03:40 AMShould you buy into the pharma boom with GlaxoSmithKline plc and Shire plc? -
06/20/16 02:49 AMFULFIL study shows superiority of closed triple combination therapy FF/UMEC/VI versus Symbicort® Turbohaler® in improving lung function and health-related quality of life in COPD patients - [at noodls] - Issued London. ... This is an abstract of the original noodl. To continue reading this document, click here for the original version.
06/20/16 01:19 AMFULFIL Study Results Closed Triple EU - [at noodls] - Issued: Monday 20 June 2016, London UK - LSE Announcement FULFIL study shows superiority of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohalerin improving lung function and health-related ...
06/17/16 04:31 AMFactory snag hits GSK supply, causing Danish anaesthetic shortage - [Reuters - UK Focus] - Manufacturing problems at a factory in Italy have disrupted production of some GlaxoSmithKline medicines, leading to shortages of a commonly used opioid anaesthetic in Denmark. The British drugmaker said ...
06/17/16 03:00 AMGlaxoSmithKline plc and Royal Dutch Shell plc: 2 income champions to protect you from Brexit risks -
06/16/16 04:20 PMJuly 29th Options Now Available For GlaxoSmithKline (GSK)
06/16/16 09:41 AM3 High-Yield Dividend Stocks You Should Buy as Brexit Fears Swirl -
06/16/16 08:40 AMHC Stocks Overview: GlaxoSmithKline plc (ADR) (NYSE:GSK), Novavax, Inc. (NASDAQ:NVAX) - share market updates (press release)
06/16/16 08:39 AMNotable Analyst's Ranking Preview: GlaxoSmithKline PLC (NYSE:GSK) , UnitedHealth Group Incorporated (NYSE:UNH) - Street Updates
06/15/16 04:24 PMEye Catching Stock for investors: GlaxoSmithKline plc (NYSE:GSK) - News Oracle
06/15/16 04:24 PMEarnings Analysis to Watch: GlaxoSmithKline plc (NYSE:GSK), Target Corp. (NYSE:TGT) - Beacon Chronicle
06/15/16 08:57 AMAnalyst Price Target Update on GlaxoSmithKline PLC (NYSE:GSK) - Trade Calls
06/15/16 08:20 AMPerrigo Rises Further as Takeover Rumor Swirls -
06/14/16 04:11 PMGlaxoSmithKline PLC (NYSE:GSK): The Buzzing Stock - Stocks Daily
06/14/16 12:19 PMGlaxoSmithKline (GSK) Stock Lower as Chairman of Vaccines Retires -
06/14/16 09:06 AMGlaxoSmithKline vaccines unit chairman to retire
06/14/16 09:06 AMGlaxoSmithKline says vaccines business head to retire
06/14/16 05:28 AMGlaxo’s Vaccines Chairman Moncef Slaoui to Retire Next Year -
06/13/16 04:01 PMNo respite for capital market this week – Analysts
06/13/16 07:01 AMHC Stocks To Observe: CVS Health Corp (NYSE:CVS), GlaxoSmithKline plc (ADR) (NYSE:GSK) - share market updates (press release)
06/13/16 07:01 AMRevenue Estimates of the Stock: GlaxoSmithKline plc (NYSE:GSK) - News Oracle
06/13/16 07:01 AMGlaxoSmithKline plc (NYSE:GSK) & Cypress Semiconductor (NASDAQ:CY) Stocks in Focus - Wall Street 24
06/13/16 02:50 AMWill HSBC Holdings plc or GlaxoSmithKline plc continue to offer sky-high yields? -
06/12/16 08:21 AM9:21 am GlaxoSmithKline and Pfizer (PFE) joint company ViiV Healthcare announces FDA approval of a sNDA for dolutegravir 10mg and 25mg oral tablets -
06/11/16 07:04 AMKeep an eye on Analyst Actions: Abbott Laboratories (NYSE:ABT) , GlaxoSmithKline PLC (NYSE:GSK) - Street Updates
06/10/16 07:03 AMHC Stocks in Top Row: Immune Pharmaceuticals Inc (NASDAQ:IMNP), GlaxoSmithKline plc (ADR) (NYSE:GSK) - share market updates (press release)
06/10/16 03:00 AMAre GlaxoSmithKline plc, Indivior plc and Alliance Pharma plc buys ahead of a potential Brexit? -
06/09/16 04:27 PMPerformance to see: GlaxoSmithKline plc (NYSE:GSK) - News Oracle
About GlaxoSmithKline plc

GlaxoSmithKline plc logoGlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK's Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSK's Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: GSK
  • CUSIP:
Key Metrics:
  • Previous Close: $40.80
  • 50 Day Moving Average: $41.98
  • 200 Day Moving Average: $40.88
  • P/E Ratio: 110.27
  • P/E Growth: 30.70
  • Market Cap: $99.10B
  • Current Quarter EPS Consensus Estimate: $2.31 EPS
Additional Links:
GlaxoSmithKline plc (NYSE:GSK) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha